Use/Consumption. Substance-related problems. Substance use disorders. Addiction

Similar documents
ADHD & Addictions -What We Know

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

The Neurobiology of Addiction

Neurobiology of Addiction

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

Understanding Addiction and Dugs Of Abuse

590,000 deaths can be attributed to an addictive substance in some way

PSYCHOLOGICAL DISORDERS CHAPTER 13 MEYERS AND DEWALL

Behavioral Therapies for Methamphetamine Use

Understanding Alcohol And Other Drugs Of Abuse

substance use and mental disorders: one, the other, or both?

Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5

MH ID: Misuse of Psychotropic Medications. Jarrett Barnhill MD UNC School of Medicine Jarrett November 19, 2013

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

9/12/2012 ALCOHOL AND DRUG USE, ASSOCIATED DISORDERS AND THEIR PSYCHIATRIC COMORBIDITIES IN U.S. ADULTS OBJECTIVES

Overview of Adolescent Substance Abuse & Treatment

Opioid Epidemic Update

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

4/28/2016. You don t need to remember. ASAM Definition of Addiction. ASAM Definition

Reframing Addictions

Serena M. King, Ph.D., L.P. Associate Professor of Psychology

GIOCO D AZZARDO PATOLOGICO E COMORBIDITÀ PSICHIATRICHE

What are Substance Use Disorders?

Understanding Addiction: Why Can t Those Affected Just Say No?

THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH

HIV and alcohol use: why is risk reduction in alcohol use important in HIV care?

Substance Use Disorders: brains, behavior, and diagnosis. Jessica Gregg, MD, PhD OHSU Addiction Medicine Section

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

Survey of Temporary Assistance For Needy Families (TANF) Recipients

A Clinical Translation of the Research Article Titled Antisocial Behavioral Syndromes and. Additional Psychiatric Comorbidity in Posttraumatic Stress

GAP e comorbidità psichiatrica. Eugenio Aguglia. Università di Catania, Dipartimento di Medicina Clinica e Sperimentale

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Disclosure Information I have the following financial relationships to disclose:

Addiction and Change 11/8/2017. Roots of Substance Use Disorders and Paths to Recovery: A Consumer-Centered, Collaborative & Comprehensive Care Model

by popular demand: Addiction II

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Navigating the. Addiction. A Four-Letter Word!!! What is Addiction? Definition of Addiction: Definition of Addiction: (cont)

Neurobiology of addiction and why it is important

CHAPTER 2. THE NEUROBIOLOGY OF SUBSTANCE USE, MISUSE, AND ADDICTION

Management of Marijuana Addiction

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V

Diffusing the Stress in Financial Distress: The Intersection of Bankruptcy and Mental Health

Listen & Hear 4Lo

Supplementary Appendix

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

Neuroscience for Non-scientists

Psychosis, Mood, and Personality: A Clinical Perspective

Helping Behaviors and Alcohol Use Disorders

Opiate Use Disorder and Opiate Overdose

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

The Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo

Doug Sellman Professor of Psychiatry & Addiction Medicine National Addiction Centre University of Otago, Christchurch

Tony Klein, MPA, CASAC, NCACII

Treatment of Anxiety as a Cooccurring Disorder

Addictions Neuroclinical Assessment: A Dimensional Approach to Addiction

Contingency Management with Adolescents and Their Families

What is the DSM. Diagnostic and Statistical Manual of Mental Disorders Purpose

Concurrent Disorders

Substance Abuse and Addictions Substance abuse: a pattern of substance use that produces clinically significant impairment or distress.

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Pain and Addiction. Edward Jouney, DO Department of Psychiatry

Comorbidity of Substance Use Disorders and Psychiatric Conditions-2

Attention deficit hyperactivity disorder (ADHD), Conduct disorder biological treatments

Neurobiology of Pain and Addiction

Slide 1. Slide 2. Slide 3 Similar observations in all subsets of the disorder. Personality Disorders. General Symptoms. Chapter 9

Problematic opioid need in chronic pain: Part 2: Complex persistent dependence and the confusing patient experience on and off opioids

Substance Use Disorders: What Can We Do to Help Break the Cycle of Addiction

Jim Giese, Ph.D., LP Affiliated Clinical Services

The Neuroscience of Addiction: A mini-review

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

Evidence-Based Treatment Approaches for Gambling Disorder

Leading Causes of Death

Gambling und Gaming:

Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents

Substance Use Disorders

Why Should I Care? Substance Use, Mental Health and Problem Gambling. Charles D. Maurer, PhD NAADAC 2014 Annual Conference Seattle, WA

Alcohol And Mood Disorders. L.E. Smit, MD, FRCPC. Objectives. February 8, 2007

Mood Disorders and Addictions: A shared biology?

The addiction model is not appropriate for use with food. Expertise and research funding. Peter Rogers. Potatoes give you drug fix

True or False? Chapter 14 Psychological Disorders. What is Abnormal Behavior? 12/9/10. Characteristics of Abnormal Behavior

Update on Medications for Tobacco Cessation

Key Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012

SUBSTANCE ABUSE A Quick Reference Handout by Lindsey Long

P1: OTA/XYZ P2: ABC JWST JWST066-Adinoff July 16, :36 Printer Name: Yet to Come. Introduction COPYRIGHTED MATERIAL

Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders. William L. Bograkos, MA, DO, FACOEP

Suicidal and Non-Suicidal Self- Injury in Adolescents

Alcoholism has been demonstrated to have a genetic component, especially among men.

Understanding the Brain: What Drugs Can Tell Us

Clinical Evaluation: Assessment Goals

Learning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking

Anxiety vs. Fear. Anxiety. Fear. Both involve physiological arousal. Both can be adaptive. Apprehension about a future threat

Pain, Suffering, Over-Prescribing and Addiction What Have We Done, What Can We Do?

Psychological Disorders. Schizophrenia Spectrum & Other Psychotic Disorders. Schizophrenia. Neurodevelopmental Disorders 4/12/2018

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences.

The Neurobiology of Addiction. Angela Haliburda, DO

Transcription:

Use/Consumption Substance-related problems Substance use disorders Addiction

It s not that Billy [Martin] drinks a lot, it s just that he fights a lot when he drinks a little. ~ Dick Young

Neglect of interests; increased time to obtain, use or recover

What if.? Criterion 1 2 3 4 5 6 7 8 9 10 11 ê ê ê ê ê ê ê ê ê ê ê = Abuse Criterion =Dependence Criterion It s the algorithm!

SUD Criterion DSM-IV DSM-5 Use in hazardous situations Failure to fulfill major role responsibilities ü ü Social or interpersonal problems ü ü Legal Difficulties Tolerance Withdrawal ü ü Impaired Control ü ü Attempts or desire to cut down ü ü Time spent (obtaining, using, recovering) ü ü Important activities given up ü ü Use despite physical or psychological problems ü ü Craving A B U S E D E P E N D E N C E ü ü ü ü ü ü

DSM-5 Scorecard Legal Problems Dropped Abuse/Dependence Distinction Dropped Craving Criterion Added ü ü ü 2/11 Algorithm Retention of Hazardous Use Criterion Lack of a Conceptual Core ü ü ü Severity Grading?

Prevalence of Different AUD Definitions (Past Year) Percent of US adults 21+ with an AUD 14 12 10 8 6 4 2 12.4 11.1 What percentage makes the most sense?? 7.3 5 4.5 2.9 0 DSM-5 2/11 Any DSM-IV AUD DSM-5 3/11 DSM-IV Dependence DSM-5 4/11 DSM-5 5/11 Martin, Steinley, Verges and Sher (2011). The proposed DSM-5 2/11 symptom algorithm for SUDs is too lenient. Psychological Medicine, 41, 2008-2010.

Heterogeneity: Symptom Configurations Among Those with Exactly 2 Symptoms (n = 1,486) Larger/Longer and Hazardous Use 18% Larger/Longer and Quit/Cut Down 14% Larger/Longer and Withdrawal 10% Tolerance and Quit/Cut Down 10% Larger/Longer and Tolerance 6% Martin, Steinley, Verges and Sher (2011). The proposed DSM-5 2/11 symptom algorithm for SUDs is too lenient. Psychological Medicine, 41, 2008-2010.

60 Severity: 5+ Drinks at Least Weekly for Different AUD Thresholds 54.1 50 47.2 Percent of US adults age 21+ 40 30 20 10 28.3 38.1 0 2 3 4 5 Exact Number of DSM-5 Symptoms Martin, Steinley, Verges and Sher (2011). The proposed DSM-5 2/11 symptom algorithm for SUDs is too lenient. Psychological Medicine, 41, 2008-2010.

Polythetic approach to diagnosis means Not all individuals who diagnose share overlapping symptoms Many different combinations possible (2036!!) Do these make a difference? SUD Severity Mild Mod. Severe # Criteria Met 2 3 4 5 6 7 8 9 10 11 # of Possible Configurations 55 165 330 462 462 330 165 55 11 1

ORadj 12-Month DSM-5 AUD & Psychiatric Disorders Psychiatric Disorder Mild AUD Mod AUD Severe AUD Any DUD 3.0 5.3 11.8 Nicotine dep 2.2 3.5 6.0 Major Dep 1.3 1.8 2.9 Dysthymia 1.1 1.4 2.7 Bipolar I 1.9 3.3 4.9 Bipolar II 1.8 1.6 3.3 Panic 1.5 1.9 3.4 Adjusted for Sociodemographic Characteristics Grant et al. JAMA Psychiatry. 2015 Aug;72(8):757-66 supplement

ORadj 12-Month DSM-5 AUD & Psychiatric Disorders Psychiatric Disorder Mild AUD Mod AUD Severe AUD Panic 1.5 1.9 3.4 Agoraphobia 1.7 1.7 3.0 Social phobia 1.0 1.7 2.3 GAD 1.6 1.4 3.1 PTSD 1.4 1.8 3.7 Antisocial PD 1.9 2.8 4.6 Borderline PD 2.1 2.9 5.9 Schizotypal PD 1.6 2.2 4.1 Adjusted for Sociodemographic Characteristics Grant et al. JAMA Psychiatry. 2015 Aug;72(8):757-66 supplement

Internalizing and Externalizing Factor Structure of Mental Disorders (Krueger, 1999) Best-fitting model for the entire National Comorbidity Survey, a 3-factor variant of the 2-factor internalizing/externalizing model. All parameter estimates are standardized and significant atp<.05

Shared Etiology Among Externalizing Conditions Hicks BM, Foster KT, Iacono WG, McGue M. (2013) Genetic and Environmental Influences on the Familial Transmission of Externalizing Disorders in Adoptive and Twin Offspring. JAMA Psychiatry. 2013;70(10):1076-1083.

Prevalence (in %) 30 25 20 15 10 severe moderate mild 5 0 18-29 30-44 45-64 65+ Age Grant et al. JAMA Psychiatry. 2015 Aug;72(8):757-66

Percentage diagnosed with Drug Use Disorder 9 8 7 6 5 4 3 2 1 0 mod/severe mild 18-29 30-44 45-64 65+ Age Grant, et al. JAMA Psychiatry. 2016;73(1):39-47

Percentage diagnosed with Alcohol Use Disorder at 3-year F/U 30 25 20 15 10 5 0 Persistence Recurrence New Onset 18-20 21-24 25-29 30-39 40-49 50-59 60+ Age at Baseline Verges et al. (2012)

Percentage diagnosed with Alcohol Use Disorder at 3-year F/U 10 9 8 7 6 5 4 3 2 1 0 Persistence Recurrence New Onset 18-20 21-24 25-29 30-39 40-49 50-59 Age at Baseline Verges et al. (2013) Am J Pub Health

60 50 40 30 20 10 Men 0 29/30 35 S-S M-M D-D E-M S-M D-M M-D 60 50 40 30 20 10 Women 0 29/30 35 S-S M-M D-D E-M S-M D-M M-D Bachman et al., 2008

Men 35 30 25 20 15 10 5 0 29/30 35 S-S M-M D-D E-M S-M D-M M-D Women 35 30 25 20 15 10 5 0 29/30 35 S-S M-M D-D E-M S-M D-M M-D Bachman et al., 2008

40 Men 40 Women 30 30 20 20 10 10 0 29/30 35 S-S M-M D-D E-M S-M D-M M-D 0 29/30 35 S-S M-M D-D E-M S-M D-M M-D Bachman et al., 2008

The Transformation of Zia to

Screenshot of Zia McCabe video

1 Standard deviations 0.8 0.6 0.4 0.2 0 10 20 30 40 50 60 70 80 Age Conscientiousness Emotional Stability

Impulsivity Neuroticism 5 10 4.5 4 9.5 9 8.5 3.5 8 3 2.5 7.5 7 6.5 2 18 25 29 35 6 18 25 29 35 Littlefield, A., Sher, K. J., & Wood, P. K., 2009

4 3.5 3 2.5 2 1.5 1 0.5 0 18 19 20 21 25 26 35 Littlefield, A., Sher, K. J., & Wood, P. K., 2009

Littlefield, A., Sher, K. J., & Wood, P. K., 2009

Littlefield, A., Sher, K. J., & Wood, P. K., 2009

Parenting Behavior Model of SUD Vulnerabilit (adapted from Sher, 1991) Active Parental Drinking Centrality of Personality in Etiology of SUDs Family History of Alcoholism Life Stress Emotional Distress Temperament/ Personality Cognitive Dysfunction School Failure Coping Ability Peer Influence Pathological Substance Involvement Drug Sensitivity Substance Use Expectancies

Internal External Positive Reinforcement Negative Reinforcement Enhancement Coping Social Conformity Cooper, 1995

4 Drinking Motivations 3 2 1 0 Cooper et al. (2016) The Oxford handbook of substance use and substance use disorders. Vol 1, pp. 375-421.

4 Marijuana Motivation 3 2 1 0 Cooper et al. (2016) The Oxford handbook of substance use and substance use disorders. Vol 1, pp. 375-421.

4 Tobacco Motivation 3 2 1 0 Cooper et al. (2016) The Oxford handbook of substance use and substance use disorders. Vol 1, pp. 375-421

Screenshot of clip video 10 to 1:04

Screenshot of clip video 9 to 1:37

Key concepts Addictive substances have initial positively valenced effects Over time, the nature of drug responses change Tolerance Withdrawal Incentive motivation These changes are durable Multiple processes may be involved Incentive sensitization Allostasis Habit formation

Neurobiology of Addiction.George F. Koob, Ph.D. FOCUS 2011;9:55-65.

Incentive-Sensitization Theory -Addictive drugs share the ability to produce long-lasting changes brain organization. -The brain systems that are changed include those normally involved in the process of incentive motivation and reward. - The critical neuroadaptations for addiction render these brain reward systems hypersensitive ( sensitized ) to drugs and drug-associated stimuli. -The brain systems that are sensitized do not mediate the pleasurable or euphoric effects of drugs (drug liking ), but instead they mediate a subcomponent of reward termed incentive salience or wanting

Berridge and Robinson (2016). Liking, wanting, and the incentive-sensitization theory of addiction. American Psychologist, 71, 670-679.

Measuring Incentive Salience? Drug-related attentional bias

RUM SOFA BED DOG POT SODA BOAR RAIN ROACH BEER SHOT HIT HIKE BUILD SMOKE STEAK PILLOW CAT BIRD COKE PILL CHILD HOTEL LAKE TOKE PHONE GIRL WINE

SELECTED EXAMPLES OF HEDONIC-AFFECTIVE PHENOMENA Example First Few Stimulations State A (input present) State B (input gone) After Many Stimulations State A (input present) State B (input gone) Dogs receiving electric shocks in harness large cardiac acceleration slow deceleration, small overshoot small acceleration or none quick deceleration, large overshoot IV opiate use euphoria, rush, pleasure craving, aversive withdrawal signs, short duration loss of euphoria, normal feeling, relief intense craving, abstinence agony, long duration

Opponent-Process Theory (Solomon & Corbit 1974) Observed A State B State Early Mid Late Early Mid Late First Several Times After Many Times

Affective Response to the presentation of a drug Initial experience of a drug with no prior drug history Individual with repeated frequent drug use Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97-129.

Koob, G. F. (2003). Alcoholism: allostasis and beyond. Alcoholism: Clinical and Experimental Research, 27(2), 232-243.

Neuroplasticity in Brain Circuits associated with the Development of Addiction Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35(1), 217-238.

Habit Learning Habitual control of instrumental behavior emerges gradually with repeated performance and is relatively unaffected by changes either in outcome value (e.g., devaluation) or in instrumental contingency Yin, H. H., & Knowlton, B. J. (2006). The role of the basal ganglia in habit formation. Nature Reviews Neuroscience, 7(6), 464-476.

Representation of limbic circuitry, with tentative localization of functions involved in drug addiction Everitt, B. J., & Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature neuroscience, 8(11), 1481-1489.

Impulsive Reflective

Behavioral Measures of Impulsivity Dick, D. M., Smith, G., Olausson, P., Mitchell, S., Leeman, R., O Malley, S. S., & Sher, K. J. (2010). Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addiction Biology, 15, 217-226.

Key Concepts Shared pathology with other externalizing spectrum disorders Deficits in executive control/problems in impulsivity Multidimensional constructs Excessive reward seeking/approach motivation Associated with early onset problems Associated with poor parenting and association with deviant peers

1: Schutz, 2012; 2: Litten et al., 2015; 3: Sher, 2015

Erickson, 2011

Impulsive/Automatic/Fast Attentional Retraining Approach Retraining Cue exposure Drug Rx s targeting relevant neurocircuitry associated with behavioral targets (or modulation of learning) reward or habit Reflective/Controlled/Slow Self-control training Motivational Interviewing Various forms of CBT Drug Rx s targeting relevant neurocircuitry with behavioral targets (or modulation of learning) on executive function